Category: neuroendocrine tumors

Sean P. Cleary MD Nov 4 , 2021

Dr. Sean Cleary to Be Featured Guest for CCF’s Luncheon with the Experts

October 31, 2021

Sean P. Cleary, MD, surgical oncologist and hepatobiliary and pancreas surgeon, will be the featured guest for Facebook Live Luncheon with the Experts on Thursday, November 4, 2021 from 12 noon to 1 pm, EST.

 

Dr. Cleary is a member of the multidisciplinary

READ MORE
Karel Pacak, MD, PhD, DSc Oct 21, 2021

Dr. Karel Pacak to Be Featured Guest for CCF’s Luncheon with the Experts

October 17, 2021

Karel Pacak, DSc, MD, PhD, an internationally recognized expert in the diagnosis and treatment of neuroendocrine tumors, especially pheochromocytoma and paraganglioma, will be the featured guest for Luncheon with the Experts on Thursday, October…

READ MORE
Sandy D. Kotiah, MD Sept 30

Dr. Sandy Kotiah to Be Featured Guest for CCF’s Luncheon with the Experts

September 25, 2021

Sandy D. Kotiah, MD, medical oncologist and hematologist, will be the featured guest for Facebook Live Luncheon with the Experts on Thursday, September 30, 2021 at 12 noon Eastern Time. Dr. Kotiah is Director of the Neuroendocrine Tumor Center at Mercy

READ MORE
Jerome S. Zacks, MD Aug26

Dr. Jerome S. Zacks to Be Featured Guest for CCF’s Luncheon with the Experts

August 21, 2021

Jerome S. Zacks, MD, cardiologist, will be the featured guest for Facebook Live Luncheon with the Experts on Thursday, August 26, 2021 from 12 noon to 1 pm, Eastern Time.

Dr. Zacks has extensive experience caring for patients with carcinoid heart disease.…

READ MORE
Nancy Sharma,MD,May 20,2021

Dr. Nancy Sharma to be Featured Guest for Luncheon with the Experts

May 19, 2021

Nancy Sharma, MD, medical oncologist and hematologist at Swedish Cancer Institute in Issaquah, Washington, will be the featured guest for CCF’s Facebook Live Luncheon with the Experts on Thursday, May 20 from 12 noon to 1 pm, Eastern Time.

Growing up …

READ MORE
NCCN Guidelines, Neuroendocrine and Adrenal Tumors_2

Detectnet (copper Cu 64 dotatate injection) Now Included in NCCN Guidelines® for Neuroendocrine Tumors

May 10, 2021

The newest FDA-approved PET imaging agent for neuroendocrine tumors — DetectnetTM (copper Cu 64 Dotate injection) — is now included in the National Comprehensive Cancer Network ® (NCCN) Clinical Practice Guidelines in Oncology – Neuroendocrine

READ MORE
Survey, DIRECT-NETS_3, Sept 2020

Understanding Patient Preferences in Neuroendocrine Tumor Treatments

September 27, 2020

When you meet with your healthcare team do you discuss what is important to you as you consider neuroendocrine tumor treatment options?  You can help physicians better understand patient-centered treatment decision making by participating in this…

READ MORE
NANETS COVID-19 Program, April 23, 2020_collage_3

NANETS Webinar on COVID-19 for the Neuroendocrine Tumor Community

April 20, 2020

A panel of 10 neuroendocrine tumor (NET) medical experts will gather for an online conversation about COVID-19 and its impact on NET patients.  Patients, families, and caregivers are invited to submit questions and panelists will answer as many as possible…

READ MORE
Progastrin Study, Blood-Based Biomarker for Detection of NENs

Progastrin, Novel Blood-Based Biomarker for Detection of Neuroendocrine Neoplasms

February 6, 2020

Clinicians and researchers at the University of Kentucky Division of Medical Oncology, College of Pharmacy, School of Medicine and Department of Surgical Oncology;  ECS Progastrin in Switzerland;  Centre Hospitalier Lyon-Sud in France;  and Biospecimen…

READ MORE
NET Webinar, November 21, 2019

Surgical Management of Neuroendocrine Tumors, November 21 Webinar for Patients and Caregivers

November 13, 2019

You’re invited to participate in a Neuroendocrine Tumor Awareness Month Webinar on November 21 from 7 to 9 pm, Eastern Time, presented by the American Association of Endocrine Surgeons (AAES). Four national experts will discuss the surgical management…

READ MORE